Beth Senko

Beth Senko, CFA

Senior Analyst

Beth Senko, CFA is a Senior Analyst at Zacks Investment Research

Beth joined Zacks Small-Cap Research in early 2018 and has 35 years of equity research experience. She started her career as small cap growth analyst for Forstmann-Leff Associates, a $4 billion money manager in New York. She moved to the sell-side to cover the medical device and service space for Robinson-Humphrey Company in Atlanta. While at Morgan Stanley, the Wall Street Journal ranked her #2 in their annual “Best on the Street” survey in the healthcare services space and Institutional Investor named her “Best Up-and-Comer” in their first survey of young analysts.

She was part of Lehman’s healthcare research team before moving to Bain & Company as a consultant and part of the original team in Bain’s New York office. She returned to Wall Street in 2002 to cover U.S. healthcare and pharmaceuticals for ABN-AMRO and the broad healthcare space for Williams Capital, L.P. In 2009 she again was named to the Wall Street Journal’s “Best on the Street” survey for her work in medical devices and technology, ranking third out of more than 40 eligible analysts.

She graduated from Rice University with a degree in Materials Science and is a Chartered Financial Analyst.

Beth has covered firms in the following Sectors & Industries:
Healthcare: Addiction Treatment, Biopharma, Diagnostics

beth senko's universe includes